JPMorgan Chase & Co. lowered shares of Sotera Health (NYSE:SHC – Get Rating) from an overweight rating to an underweight rating in a research note released on Wednesday, Marketbeat Ratings reports. They currently have $9.00 price objective on the stock, down from their previous price objective of $26.00.
A number of other brokerages have also commented on SHC. Wolfe Research lowered Sotera Health from an outperform rating to a peer perform rating and set a $26.00 price objective on the stock. in a research report on Thursday, June 9th. The Goldman Sachs Group downgraded shares of Sotera Health from a buy rating to a neutral rating and cut their price objective for the stock from $23.00 to $9.00 in a research report on Tuesday. Finally, Barclays cut their price objective on shares of Sotera Health from $24.00 to $22.00 and set an equal weight rating for the company in a research report on Wednesday, July 13th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of Hold and an average target price of $20.86.
Sotera Health Price Performance
NYSE SHC opened at $7.32 on Wednesday. Sotera Health has a twelve month low of $7.16 and a twelve month high of $27.38. The company has a debt-to-equity ratio of 2.83, a quick ratio of 2.53 and a current ratio of 2.81. The stock has a market capitalization of $2.07 billion, a PE ratio of 16.27 and a beta of 0.44. The stock has a 50-day simple moving average of $17.54 and a 200 day simple moving average of $19.61.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. New York State Common Retirement Fund grew its stake in shares of Sotera Health by 7.9% during the first quarter. New York State Common Retirement Fund now owns 151,959 shares of the company’s stock worth $3,291,000 after buying an additional 11,174 shares during the last quarter. DekaBank Deutsche Girozentrale grew its stake in shares of Sotera Health by 12.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 44,800 shares of the company’s stock worth $990,000 after buying an additional 4,800 shares during the last quarter. Verition Fund Management LLC bought a new stake in shares of Sotera Health during the first quarter worth $3,693,000. Bank of Montreal Can bought a new stake in shares of Sotera Health during the fourth quarter worth $2,698,000. Finally, Frontier Capital Management Co. LLC grew its stake in shares of Sotera Health by 30.8% during the first quarter. Frontier Capital Management Co. LLC now owns 382,014 shares of the company’s stock worth $8,274,000 after buying an additional 89,974 shares during the last quarter. 88.38% of the stock is currently owned by institutional investors and hedge funds.
About Sotera Health
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
- Get a free copy of the StockNews.com research report on Sotera Health (SHC)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.